NM_130782.3:c.267A>T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_130782.3(RGS18):c.267A>T(p.Lys89Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000292 in 1,611,568 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_130782.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGS18 | ENST00000367460.4 | c.267A>T | p.Lys89Asn | missense_variant | Exon 3 of 5 | 1 | NM_130782.3 | ENSP00000356430.3 | ||
RGS18 | ENST00000481707.5 | n.316A>T | non_coding_transcript_exon_variant | Exon 4 of 6 | 3 | |||||
RGS18 | ENST00000491030.1 | n.229A>T | non_coding_transcript_exon_variant | Exon 3 of 3 | 3 | |||||
RGS18 | ENST00000492967.5 | n.391A>T | non_coding_transcript_exon_variant | Exon 3 of 5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251222Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135780
GnomAD4 exome AF: 0.0000288 AC: 42AN: 1459372Hom.: 0 Cov.: 28 AF XY: 0.0000234 AC XY: 17AN XY: 726176
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152196Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.267A>T (p.K89N) alteration is located in exon 3 (coding exon 3) of the RGS18 gene. This alteration results from a A to T substitution at nucleotide position 267, causing the lysine (K) at amino acid position 89 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at